Hagar Lands Funding To Develop Noninvasive Glucose Monitoring Watch

The Israeli company touts its GWave monitor as the world's first non-invasive continuous glucose monitoring technology that uses radiofrequency waves to measure glucose levels in the blood.

Blood glucose and insulin molecules • Source: Alamy

Hagar is planning to put its GWave non-invasive continuous glucose monitoring (CGM) technology in a smartwatch and eventually sell the technology to a larger medtech player that can market it globally.

Unlike other non-invasive CGM technologies that infer blood glucose levels from measurements in the users’ interstitial fluid, GWave's technology images...

More from Financing

More from Business